RECRUITING

Postpartum Hypertension Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to assess which blood pressure medication (intravenous labetalol or oral nifedipine) works better in treating severely elevated blood pressure in women who have just delivered a baby.

Official Title

Oral Nifedipine Versus Intravenous Labetalol for Postpartum (PP) Hypertensive Emergency: a Randomized Clinical Trial (RCT)

Quick Facts

Study Start:2022-07-04
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05139238

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Whitney A. Booker, MD
CONTACT
212-305-7334
wb2322@cumc.columbia.edu

Principal Investigator

Whitney A. Booker, MD
PRINCIPAL_INVESTIGATOR
Columbia University

Study Locations (Sites)

Columbia University Irving Medical Center
New York, New York, 10032
United States

Collaborators and Investigators

Sponsor: Columbia University

  • Whitney A. Booker, MD, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-04
Study Completion Date2027-12

Study Record Updates

Study Start Date2022-07-04
Study Completion Date2027-12

Terms related to this study

Keywords Provided by Researchers

  • Hypertension
  • Hypertensive Emergency
  • Postpartum
  • Preeclampsia

Additional Relevant MeSH Terms

  • Postpartum Pregnancy-Induced Hypertension
  • Postpartum Preeclampsia
  • Pregnancy-Induced Hypertension in Postpartum
  • Hypertensive Emergency